IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 212 filers reported holding IMMUNOMEDICS INC in Q3 2019. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $7,270,000 | +13.1% | 524,140 | +56.6% | 6.06% | -22.4% |
Q1 2019 | $6,430,000 | -49.6% | 334,724 | -62.6% | 7.80% | +48.3% |
Q4 2018 | $12,767,000 | -56.2% | 894,679 | -36.0% | 5.26% | -5.7% |
Q3 2018 | $29,132,000 | -7.4% | 1,398,577 | +5.2% | 5.58% | +14.6% |
Q2 2018 | $31,460,000 | +99.1% | 1,329,104 | +22.9% | 4.87% | +87.2% |
Q1 2018 | $15,799,000 | +141.7% | 1,081,410 | +167.3% | 2.60% | +115.9% |
Q4 2017 | $6,537,000 | -41.0% | 404,528 | -48.9% | 1.20% | -57.7% |
Q3 2017 | $11,074,000 | +169.7% | 792,106 | -37.3% | 2.85% | +12.9% |
Q3 2016 | $4,106,000 | – | 1,263,276 | – | 2.52% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Avoro Capital Advisors LLC | 17,714,461 | $368,992,000 | 16.94% |
ACUTA CAPITAL PARTNERS, LLC | 2,055,500 | $42,816,000 | 15.27% |
Foresite Capital Management III, LLC | 2,691,729 | $56,069,000 | 12.37% |
Foresite Capital Management IV, LLC | 1,231,543 | $25,653,000 | 8.41% |
NEXTHERA CAPITAL LP | 1,398,577 | $29,132,000 | 5.58% |
Palo Alto Investors LP | 5,013,764 | $104,437,000 | 4.22% |
Ghost Tree Capital, LLC | 883,823 | $18,410,000 | 3.91% |
First Light Asset Management, LLC | 1,151,622 | $23,988,000 | 3.87% |
DLD Asset Management, LP | 3,403,000 | $70,918,000 | 3.51% |
RA Capital Management | 3,119,778 | $64,985,000 | 3.47% |